Detalhe da pesquisa
1.
HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer.
Breast Cancer Res Treat
; 190(1): 155-163, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34409551
2.
Pertuzumab in HER2-positive early breast cancer: current use and perspectives.
Future Oncol
; 15(16): 1823-1843, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30938542
3.
Synergistic actions of Alpelisib and Melatonin in breast cancer cell lines with PIK3CA gene mutation.
Life Sci
; 324: 121708, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086897
4.
Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis.
Cancer Treat Rev
; 62: 123-132, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29108713